INNOCARE PHARMA LIMITED

Insiders InnoCare Pharma Limited

Equities

9969

KYG4783B1032

Market Closed - Hong Kong S.E. Other stock markets 09:08:20 14/05/2024 BST			5-day change	1st Jan Change
5.13 ^HKD	-0.58%		+2.40%	-25.54%

05-14	Innocare Pharma Posts Q1 Loss	MT
05-13	InnoCare Logs Loss in Q1	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InnoCare Elects CFO	12-18	MT
InnoCare Pharma Appoints Xin Fu as Chief Financial Officer	12-18	CI
Innocare Pharma Limited Announces the Appointment of Dandan Dong as Independent Non-Executive Director	11/10/23	CI
RemeGen Names CFO	28/09/23	MT
Innocare Pharma Limited Announces Board Changes	14/07/23	CI
InnoCare Pharma Limited Announces Shan Fu Resigned as A Non-Executive Director with Effect from 27 March 2023	27/03/23	CI
InnoCare CFO Resigns	02/01/23	MT
Innocare Pharma Limited Announces Executive Changes	31/03/22	CI
InnoCare Pharma Limited Announces Executive Changes	22/03/22	CI
InnoCare Pharma Appoints Dr. Sean Zhang as Chief Medical Officer	01/03/21	CI
InnoCare Pharma Limited Announces Change of the Chief Medical Officer	28/02/21	CI
InnoCare Pharma Limited Announces Change of Company Secretary	09/02/21	CI
InnoCare Pharma Limited Appoints Manish Tandon as Vice President of Business Development	12/10/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer